post-bariatric hypoglycemia Eiger BioPharmaceuticals
Eiger BioPharmaceuticals completes enrolment in Prevent trial
Eiger BioPharmaceuticals has completed patient enrolment in the Phase ll Prevent trial evaluating the safety and durability of subcutaneous (SC)…
